Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DNASENSE ApS
APS
Active
Advertising protection
CVR 36036869
Niels Jernes Vej 10, 9220
Aalborg Øst
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 12 years old
14 employees
dnasense.dk
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
DNASENSE ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MT
Mads Toft Søndergaard
Management
Management
2020
Former (1)
MA
Mads Albertsen
Management
Management
2014 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AC
Anders Christian Neto de Sousa Grøn
Chairman
Chairman
2024
MN
Manoj Nirmal Dadlani
Board of Directors
Board of Directors
2024
HB
Henrik Bjørn Nielsen
Board of Directors
Board of Directors
2024
AM
Anders Mohr Christensen
Board of Directors
Board of Directors
2025
Former (1)
HK
Henrik Knudsen
Board of Directors
Board of Directors
2024 – 2024
Shareholders
As of last annual report
Clinical-Microbiomics A/S — 100%
PER HALKJÆR HOLDING ApS — 10–14.99%
Lukassen Holding ApS — 10–14.99%
MTSondergaard Holding ApS — 10–14.99%
KARST HOLDING ApS — 15–19.99%
Kjeldal Investments ApS — 10–14.99%
RWO Holding ApS — 10–14.99%
KIRK3GAARD HOLDING ApS — 10–14.99%
MADS ALBERTSEN HOLDING ApS — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
Clinical-Microbiomics A/S
Company
100%
100%
2024
PER HALKJÆR HOLDING ApS
Company
10–14.99%
10–14.99%
2021
Lukassen Holding ApS
Company
10–14.99%
10–14.99%
2021
MTSondergaard Holding ApS
Company
10–14.99%
10–14.99%
2021
KARST HOLDING ApS
Company
15–19.99%
15–19.99%
2021
Kjeldal Investments ApS
Company
10–14.99%
10–14.99%
2021
RWO Holding ApS
Company
10–14.99%
10–14.99%
2021
KIRK3GAARD HOLDING ApS
Company
10–14.99%
10–14.99%
2021
MADS ALBERTSEN HOLDING ApS
Company
25–33.32%
25–33.32%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on DNASENSE ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network